...
首页> 外文期刊>The Journal of the Association of Genetic Technologists >Duplication of the Band q21q27 on the Long Arm of Chromosome 3: A Rare Cytogenetic Event in B-Chronic Lymphocytic Leukemia (B-CLL)
【24h】

Duplication of the Band q21q27 on the Long Arm of Chromosome 3: A Rare Cytogenetic Event in B-Chronic Lymphocytic Leukemia (B-CLL)

机译:染色体长臂上的带Q21Q27的重复3:B-慢性淋巴细胞白血病(B-CLL)中的一种稀有细胞遗传学事件

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We present the case of an 83-year-old female with a long history of B-CLL followed by observation only. Twelve years after her diagnosis of CLL, routine follow-up chromosome analysis of peripheral blood revealed an abnormal metaphase with a dup(3)(q21q27) in 18 of 20 metaphase cells. To further characterize the abnormal chromosome 3, fluorescence in situ hybridization (FISH) was performed using the Abbott BCL6 probe for 3q27. An additional BCL6 signal was observed in 303 of the 500 interphase nucleiexamined. The ISCN was reported as 46,XX,dup(3)(q21q27)[1]/46,XX[2]. nuc ish(5'BCL6, 3'BCL6)x3(5'BCL6 with 3'BCL6x3)[303/500]. This abnormality was seen again in one of three available metaphases in a follow-up peripheral blood study five years later, consistent with persistent disease. Molecular genetic analysis identified the presence of somatic hypermutation of the immunoglobulin heavy chain gene variable region (IGH-V), which is recognized as an independent favorable prognostic marker in CLL. FISH analysis was negative for loss of SEC63 (6q21), amplification of MYC (8q24), loss of ATM (11q22.3), trisomy 12, loss of D13S319 (13q14.3), loss of TP53 (17p13.1) and CCND1/MYEOV IGH rearrangement [t(11;14)(q13;q32.30)]. Partial trisomy 3 is a relatively rare event seen in B-CLL, with commonly overrepresented segments including the q21-23 region and the q25-29 region of the long arm of chromosome 3, as well as changes leading to gains of 3q26-q27. The clinical significance of this finding in B-CLL is uncertain; however, our patient remains well and has not required therapy 17 years after her initial diagnosis.
机译:我们展示了一个83岁女性的案例,历史悠久的B-CLL之后只有观察。十二年后的CLL诊断后,外周血的常规随访染色体分析显示了具有杜普(3)(Q21Q27)的异常中期,其中18个中尚细胞中的18个。为了进一步表征异常染色体3,使用Abbott BCl6探针进行原位杂交(鱼)的荧光,用于3Q27。在500个间相位核胺的303中观察到另外的BCL6信号。 ISCN报告为46,XX,DUP(3)(Q21Q27)[1] / 46,XX [2]。 NUC ISH(5'BCL6,3'BCL6)X3(5'BCL6,3'BCL6X3)[303/500]。在五年后的后续外周血血液研究中,在三种可用的中源中再次看到这种异常,与持续疾病一致。分子遗传分析确定了免疫球蛋白重链基因可变区(Igh-V)的体细胞高原的存在,其在ClL中被认为是独立良好的预后标记物。 SEC63(6Q21)丧失鱼类分析,MYC的扩增(8Q24),ATM丧失(11Q22.3),三兆癣12,D13S319的丧失(13 Q14.3),TP53丧失(17P13.1)和CCND1 / Myeov Igh重排[T(11; 14)(Q13; Q32.30)]。局部三元图3是在B-CLL中看到的相对罕见的事件,具有常见的段,包括Q21-23区域和染色体3的长臂的Q25-29区,以及导致3Q26-Q27的增益的变化。这种发现在B-CLL中的临床意义是不确定的;然而,我们的患者仍然很好,并且在她初步诊断后17年没有治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号